{
  "trial_id": "NCT04039503",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, baseline HbA1c, insulin glargine dose, use of metformin, weight, estimated glomerular filtration rate (eGFR), history of cardiovascular disease, history of pancreatitis, history of diabetic retinopathy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Hemoglobin A1c",
          "baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "insulin glargine dose",
        "use of metformin",
        "weight",
        "estimated glomerular filtration rate (eGFR)",
        "history of cardiovascular disease",
        "history of pancreatitis",
        "history of diabetic retinopathy"
      ]
    },
    "processed-gen-response": "Age, gender, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, baseline HbA1c, insulin glargine dose, use of metformin, weight, estimated glomerular filtration rate (eGFR), history of cardiovascular disease, history of pancreatitis, history of diabetic retinopathy."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Daily Insulin Dose, Use of Metformin, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate (eGFR),",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hemoglobin A1c",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Duration of Diabetes",
        "Daily Insulin Dose",
        "Use of Metformin",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Estimated Glomerular Filtration Rate (eGFR)"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Mass Index, Baseline HbA1c, Duration of Diabetes, Daily Insulin Dose, Use of Metformin, Systolic Blood Pressure, Diastolic Blood Pressure, Estimated Glomerular Filtration Rate (eGFR)"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Duration, Body Mass Index, HbA1c, Insulin Dose, Metformin Use, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, eGFR, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Hemoglobin A1c",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Diabetes Duration",
        "Body Mass Index",
        "Insulin Dose",
        "Metformin Use",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Total Cholesterol",
        "Triglycerides",
        "eGFR",
        "History of Cardiovascular Disease"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes Duration, Body Mass Index, HbA1c, Insulin Dose, Metformin Use, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, Triglycerides, eGFR, History of Cardiovascular Disease."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at screening, fasting plasma glucose at screening, insulin glargine dose at screening, metformin use at screening, weight, systolic blood pressure, diastolic blood pressure, heart rate, medical history, concomitant medications.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Hemoglobin A1c",
          "HbA1c at screening"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "duration of type 2 diabetes",
        "fasting plasma glucose at screening",
        "insulin glargine dose at screening",
        "metformin use at screening",
        "weight",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "medical history",
        "concomitant medications"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of type 2 diabetes, HbA1c at screening, fasting plasma glucose at screening, insulin glargine dose at screening, metformin use at screening, weight, systolic blood pressure, diastolic blood pressure, heart rate, medical history, concomitant medications."
  }
}